Corvus Pharmaceuticals, Inc. (CRVS)

Corvus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 18, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	456	344	86	40	112	100
Market Cap Growth	170.95%	298.31%	118.11%	-64.73%	12.29%	-37.55%
Enterprise Value	383	302	56	-7	40	51
Last Close Price	6.12	5.35	1.76	0.85	2.41	3.56
PB Ratio	5.68	10.56	2.23	0.71	1.16	1.39
P/TBV Ratio	5.68	10.56	2.23	0.71	1.16	1.39
Debt / Equity Ratio	0.01	0.03	0.04	0.05	0.04	0.03
Quick Ratio	8.78	1.47	3.96	3.99	7.22	3.65
Current Ratio	8.91	1.54	4.07	4.06	7.36	3.73
Return on Equity (ROE)	-68.67%	-174.85%	-57.02%	-53.90%	-51.08%	-8.37%
Return on Assets (ROA)	-28.84%	-30.09%	-25.63%	-22.50%	-24.61%	-32.33%
Return on Capital (ROIC)	-33.34%	-46.69%	-29.52%	-25.06%	-27.38%	-36.77%
Earnings Yield	-9.90%	-18.12%	-31.32%	-104.39%	-38.55%	-6.00%
FCF Yield	-6.35%	-7.40%	-27.77%	-68.97%	-32.73%	-34.89%
Buyback Yield / Dilution	-37.88%	-26.99%	-3.16%	-11.23%	-41.98%	-0.44%

Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q